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Extensive studies have established a mutual association between genetic 
predominance and environmental factors, leading to cleft lip and palate 
(CLP). Currently, CLP is being treated using a multidisciplinary approach. 
Gene therapy has a promising future and is under development for the 
treatment of various diseases. What about CLP? Recently a statement denying 
the near future possibility of achieving a cure through somatic cell gene 
therapy (SCGT) was made.1 However, there is extensive research going on 
currently, regarding the identification of new alleles associated with CLP 
mutations. 
Even if the provision of cure through SCGT is possible, what is the 
benefit of genome wide association studies to the patient or clinician? Due 
to the unknown risks involved with therapy many organizations have already 
discontinued experimentation.1 What are the moral and ethical considerations 
that need to be considered for trials of gene therapy for the treatment of CLP, 
once all the associated genes are verified? 
Extensive scoring of genes for risk factors might not be clinically 
significant, especially in such a complex disease in which large gene-
environment interactions play a role.2 In addition, ethnic and geographic 
variations have also been documented which makes gene therapy difficult to 
achieve soon. Benefits of gene therapy must outweigh the current therapeutic 
approach and the potential risks of the new therapy, for its implementation 
and assessment.3-4 If through a miracle we develop a gene-based therapy, will 
it have wide availability and cost-effectively planned provision?5 
There is a high tendency to indulge in extensive studies to identify and 
document genes related to a certain disease without focusing on the clinical 
implications. Gene therapy can provide a new platform for diagnosis and 
prevention of such complex diseases at embryonic stages. Nevertheless, ample 
stress towards clinical assessment of therapies is vital to develop applicable 
therapeutic strategies. 
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